English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/201708
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease

AuthorsTsilingiri, Katerina; Fuente, Hortensia de la; Relaño, Marta; Sánchez-Díaz, Raquel; Rodríguez, Cristina ; Crespo, Javier; Sánchez-Cabo, Fátima; Dopazo, Ana; Alonso-Lebrero, José Luis; Vara, Alicia; Vázquez, Jesús ; Casasnovas, José María ; Alfonso, Fernando; Ibáñez, Borja; Fuster, Valentín; Martínez-González, José; Martín, Pilar; Sánchez-Madrid, Francisco
KeywordsAtherosclerosis
CD69 antigen
Oxidized low density lipoprotein
Regulatory T
Lymphocytes
Th17 cells
Issue Date8-Jan-2019
PublisherAmerican Heart Association
CitationCirculation 139(2): 243-255 (2019)
AbstractBACKGROUND: Although the role of Th17 and regulatory T cells in the progression of atherosclerosis has been highlighted in recent years, their molecular mediators remain elusive. We aimed to evaluate the association between the CD69 receptor, a regulator of Th17/regulatory T cell immunity, and atherosclerosis development in animal models and in patients with subclinical disease. METHODS: Low-density lipoprotein receptor-deficient chimeric mice expressing or not expressing CD69 on either myeloid or lymphoid cells were subjected to a high fat diet. In vitro functional assays with human T cells were performed to decipher the mechanism of the observed phenotypes. Expression of CD69 and NR4A nuclear receptors was evaluated by reverse transcription-polymerase chain reaction in 305 male participants of the PESA study (Progression of Early Subclinical Atherosclerosis) with extensive (n=128) or focal (n=55) subclinical atherosclerosis and without disease (n=122). RESULTS: After a high fat diet, mice lacking CD69 on lymphoid cells developed large atheroma plaque along with an increased Th17/regulatory T cell ratio in blood. Oxidized low-density lipoprotein was shown to bind specifically and functionally to CD69 on human T lymphocytes, inhibiting the development of Th17 cells through the activation of NR4A nuclear receptors. Participants of the PESA study with evidence of subclinical atherosclerosis displayed a significant CD69 and NR4A1 mRNA downregulation in peripheral blood leukocytes compared with participants without disease. The expression of CD69 remained associated with the risk of subclinical atherosclerosis in an adjusted multivariable logistic regression model (odds ratio, 0.62; 95% CI, 0.40-0.94; P=0.006) after adjustment for traditional risk factors, the expression of NR4A1, the level of oxidized low-density lipoprotein, and the counts of different leucocyte subsets. CONCLUSIONS: CD69 depletion from the lymphoid compartment promotes a Th17/regulatory T cell imbalance and exacerbates the development of atherosclerosis. CD69 binding to oxidized low-density lipoprotein on T cells induces the expression of anti-inflammatory transcription factors. Data from a cohort of the PESA study with subclinical atherosclerosis indicate that CD69 expression in PBLs inversely correlates with the presence of disease. The expression of CD69 remained an independent predictor of subclinical atherosclerosis after adjustment for traditional risk factors.
Publisher version (URL)http://dx.doi.org/10.1161/CIRCULATIONAHA.118.034326
URIhttp://hdl.handle.net/10261/201708
Identifiersdoi: 10.1161/CIRCULATIONAHA.118.034326
issn: 1524-4539
pmid: 30586697
Appears in Collections:(IIBB) Artículos
(CNB) Artículos
Files in This Item:
File Description SizeFormat 
Oxidized Low-Density.pdf1,93 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.